Literature DB >> 22561804

Targeting hypoxia brings breath of fresh air to cancer therapy.

Melinda Wenner Moyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22561804     DOI： 10.1038/nm0512-636b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.

Authors:  Jingli Wang; Annika Foehrenbacher; Jiechuang Su; Rita Patel; Michael P Hay; Kevin O Hicks; William R Wilson
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531
  1 in total
  10 in total

Review 1.  Janus-faced tumor microenvironment and redox.

Authors:  Valery V Khramtsov; Robert J Gillies
Journal:  Antioxid Redox Signal       Date:  2014-03-04       Impact factor: 8.401

2.  Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis.

Authors:  Bamaprasad Dutta; Ren Yan; Sai Kiang Lim; James P Tam; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2014-08-06       Impact factor: 5.911

Review 3.  Stimuli-responsive nanoparticles for targeting the tumor microenvironment.

Authors:  Jinzhi Du; Lucas A Lane; Shuming Nie
Journal:  J Control Release       Date:  2015-09-01       Impact factor: 9.776

4.  Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.

Authors:  Hani Goodarzi; Xuhang Liu; Hoang C B Nguyen; Steven Zhang; Lisa Fish; Sohail F Tavazoie
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

5.  Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

Authors:  Hong-Mei Liu; Ya-Fei Zhang; Yan-Dong Xie; Yi-Fan Cai; Bai-Yang Li; Wen Li; Ling-Yu Zeng; Yu-Ling Li; Ru-Tong Yu
Journal:  Int J Nanomedicine       Date:  2017-02-08

Review 6.  NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.

Authors:  Patricia Ahechu; Gabriel Zozaya; Pablo Martí; José Luis Hernández-Lizoáin; Jorge Baixauli; Xabier Unamuno; Gema Frühbeck; Victoria Catalán
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

7.  Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer.

Authors:  Ye Du; Na Wei; Ruolin Ma; Shu-Heng Jiang; Dong Song
Journal:  Front Oncol       Date:  2020-12-17       Impact factor: 6.244

Review 8.  Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.

Authors:  Shaojun Peng; Fengfeng Xiao; Meiwan Chen; Huile Gao
Journal:  Adv Sci (Weinh)       Date:  2021-11-19       Impact factor: 16.806

9.  Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.

Authors:  Navid Sadri; Paul J Zhang
Journal:  Cancers (Basel)       Date:  2013-04-02       Impact factor: 6.639

10.  An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative.

Authors:  Daniela Lenggenhager; Alessandra Curioni-Fontecedro; Martina Storz; Olga Shakhova; Lukas Sommer; Daniel S Widmer; Burkhardt Seifert; Holger Moch; Reinhard Dummer; Daniela Mihic-Probst
Journal:  Transl Oncol       Date:  2014-04-17       Impact factor: 4.243
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.